Endurant Capital Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q4
Sell
-919
Closed -$156K 85
2015
Q3
$156K Sell
919
-454
-33% -$77.1K 0.05% 76
2015
Q2
$868K Buy
1,373
+706
+106% +$446K 0.26% 68
2015
Q1
$343K Buy
+667
New +$343K 0.11% 86